Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne

ClinicalTrials.gov ID: NCT02815280

Public ClinicalTrials.gov record NCT02815280. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 7:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-05

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3 study to evaluate the efficacy, safety and long-term safety of the topical administration of FMX-101, 4% minocycline foam for the treatment of moderate-to-severe acne vulgaris.

Study identification

NCT ID
NCT02815280
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vyne Therapeutics Inc.
Industry
Enrollment
495 participants

Conditions and interventions

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2016 (Actual)
Primary completion
Oct 13, 2017 (Actual)
Completion
Oct 13, 2017 (Actual)
Last update posted
Jan 18, 2022

2016 – 2017

United States locations

U.S. sites
35
U.S. states
22
U.S. cities
34
Facility City State ZIP Site status
Not listed Glendale Arizona 85308 —
Not listed Rogers Arkansas 72758 —
Not listed Oceanside California 92049 —
Not listed Denver Colorado 80220 —
Not listed Hialeah Florida 33016 —
Not listed Miami Florida 33126 —
Not listed Miami Florida 33175 —
Not listed Sweetwater Florida 33172 —
Not listed Marietta Georgia 30060 —
Not listed Snellville Georgia 30078 —
Not listed Chicago Illinois 60611 —
Not listed Carmel Indiana 46032 —
Not listed Indianapolis Indiana 46256 —
Not listed Overland Park Kansas 66215 —
Not listed Owensboro Kentucky 42303 —
Not listed Crowley Louisiana 70526 —
Not listed Clarkston Michigan 48346 —
Not listed Detroit Michigan 48202 —
Not listed Montclair New Jersey 07042 —
Not listed Verona New Jersey 07044 —
Not listed Albuquerque New Mexico 87106 —
Not listed New York New York 10022 —
Not listed The Bronx New York 10458 —
Not listed Raleigh North Carolina 27612 —
Not listed Cleveland Ohio 44121 —
Not listed Hazleton Pennsylvania 18201 —
Not listed Chattanooga Tennessee 37421 —
Not listed Goodlettsville Tennessee 37072 —
Not listed Austin Texas 78746 —
Not listed New Braunfels Texas 78130 —
Not listed Port Arthur Texas 77640 —
Not listed San Antonio Texas 78229 —
Not listed Sugar Land Texas 77479 —
Not listed Salt Lake City Utah 84117 —
Not listed Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02815280, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2022 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02815280 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →